Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ritalin with and without melatonin in children with ADHD
IRCT20120215009014N235Phase 2Completed
- Sponsor
- Hamadan University of Medical Sciences
- Start
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of methylphenidate and melatonin in attention deficit hyperactivity disorder (ADHD) (2 arms), sponsored by Hamadan University of Medical Sciences. Primary endpoints: Sleep quality and Severity of ADHD clinical symptoms. Started Dec 2017; status: completed.
02
Drugs
methylphenidatemelatonin
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on IRCT20120215009014N235.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120215009014N235.